ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Tafasitamab Biosimilar - Anti-CD19 Antibody (PE) (A333472)

Recombinant humanized monoclonal antibody to CD19 (PE) for Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Tafasitamab Biosimilar - Anti-CD19 Antibody (PE)
Description
Recombinant humanized monoclonal antibody to CD19 (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Conjugate

PE

Excitation: 565nm, Emission: 578nm

Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
Synonyms
B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Tafasitamab Biosimilar - Anti-CD19 Antibody (PE) (A333472)? Please let us know so that we can list the citation on this page.

Alternative products to Tafasitamab Biosimilar - Anti-CD19 Antibody (PE) (A333472)

Proteins predicted to interact with CD19

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.7% Relevancy Score
99.7% Relevancy Score
99.7% Relevancy Score
99.2% Relevancy Score